Analyst Update: Cal-Maine Foods Inc, Tesoro Corporation, and Incyte Corporation

Analysts revised their ratings and price targets on Cal-Maine Foods Inc (CALM), Tesoro Corporation (TSO), and Incyte Corporation (INCY)

by Celeste Taylor

Published on May 9, 2016 at 3:14 PM

Analysts are weighing in on egg seller Cal-Maine Foods Inc (NASDAQ:CALM), oil stock Tesoro Corporation (NYSE:TSO), and biopharmaceutical company Incyte Corporation (NASDAQ:INCY). Here's a quick roundup of today's brokerage notes on CALM, TSO, and INCY.

  • CALM has dropped 5.8% at $48.68, after D.A. Davidson downgraded CALM to "underperform" and cut its price target to $45 from $55. The egg distributor has had a rocky six months, with its 200-day moving average capping most rebound attempts since early December. Short sellers have been especially keen on Cal-Maine Foods Inc, and 55.3% of the stock's float is currently short sold, which would take 28.4 days of trading, at CALM's average daily volume, to cover.

  • TSO is down 2.8% at $75.74, due to an energy slide and a pair of negative analyst notes. Specifically, Credit Suisse and Goldman Sachs cut the stock's price target to $100 and $99, respectively. Since exploring annual lows in February, TSO attempted a rebound, but was halted at its 20-week moving average. Tesoro Corporation's Schaeffer's put/call open interest ratio (SOIR) of 0.35 sits only in the ninth percentile of annual readings, suggesting short-term options traders have been especially call-biased lately, perhaps hoping for a rebound.

  • INCY is up 4.4% at $73.92, after announcing plans to acquire Ariad Pharmaceuticals, Inc.'s (NASDAQ:ARIA) European arm. The news has overshadowed post-earnings price-target cuts from Piper Jaffray and BMO, to $91 and $76, respectively. INCY is down 34.8% since the beginning of the year, after stopping key drug studies in the first quarter. However, INCY's 50-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX) sits at the highest point in a year, at 242.83 calls bought to open for every put. In other words, it appears option buyers have been betting on a surge for INCY.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Tesla Motors Inc, Depomed Inc, and Transocean Inc, and Analyst Downgrades: Apple Inc., Berkshire Hathaway Inc., and Intel Corporation.

 


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Work-From-Home Shift Draws Analysts to Slack Stock
Several analysts are issuing bull notes to Slack stock today
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....